Todisco Joseph 4
4 · CorMedix Inc. · Filed Feb 6, 2026
Research Summary
AI-generated summary of this filing
CorMedix (CRMD) CEO Joseph Todisco Receives Award
What Happened
Joseph Todisco, CEO of CorMedix (CRMD), was credited with 77,156 performance stock units (PSUs) effective February 4, 2026. The Form 4 reports an award/acquisition (code A) at $0.00 per share (no cash paid). This is a compensation award, not an open-market purchase or sale.
Key Details
- Transaction date: 2026-02-04; Form 4 filed: 2026-02-06 (timely filing).
- Transaction type/code: Award/Grant (A).
- Shares/units: 77,156 PSUs granted; reported acquisition price $0.00 (no cash exchanged).
- Shares owned after transaction: not specified in this filing.
- Footnote: These PSUs represent achievement of the performance conditions for the first of three performance periods tied to PSUs granted Jan 2, 2025; they remain subject to time-based vesting per the Compensation Committee (see footnote F1).
- No indication of a 10b5-1 plan, tax-withholding sale, or immediate sale of shares.
Context
PSUs are a form of equity compensation that convert into shares if performance and any time-based vesting conditions are met. Awards like this reflect company compensation decisions and do not by themselves signal an insider buying or selling shares in the market.
Insider Transaction Report
Form 4
CorMedix Inc.CRMD
Todisco Joseph
DirectorChief Executive Officer
Transactions
- Award
Common Stock
[F1]2026-02-04+77,156→ 774,749 total
Footnotes (1)
- [F1]Represents the achievement of performance stock units ("PSUs") upon the determination of the Compensation Committee of the Issuer that the performance conditions specific to the first of three performance periods were met with respect to the PSUs granted to the Reporting Person on January 2, 2025. The PSUs are subject to vesting upon satisfaction of time-based vesting conditions by the Reporting Person.
Signature
/s/ Beth Zelnick Kaufman, attorney-in-fact|2026-02-06